Moreover, GLP-1 RAs exhibit favorable outcomes [32] in reducing inflammation [33], managing obesity [34], protecting pulmonary function [35], and restoring gut microbiome composition [36]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.